Asthma Clinical Trial
— FLOATOfficial title:
Family Learning on Asthma Topics
| NCT number | NCT03894982 |
| Other study ID # | 19-0442 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | May 5, 2019 |
| Est. completion date | May 31, 2020 |
| Verified date | July 2020 |
| Source | University of Colorado, Denver |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
1. Hypothesis: The Family Learning on Asthma Topics (F.L.O.A.T) in the form of a a group
teaching environment for family education stemming from standardized education materials
on asthma, created and taught by nationally certified asthma educators will promote
optimal asthma knowledge, management and quality of life among the individuals with
asthma and their caregivers.
2. Aim 1: To determine if the availability of educational services outside of regular
clinic hours or admission status could improve asthma outcomes and decrease unnecessary
medical utilization.
3. Aim 2: By providing small-group learning environments for families, the investigators
aim to encourage families to learn from each other's experiences and to decrease stigma
around the disease.
| Status | Completed |
| Enrollment | 10 |
| Est. completion date | May 31, 2020 |
| Est. primary completion date | May 31, 2020 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 4 Years to 100 Years |
| Eligibility |
Inclusion Criteria: - Legal guardians and or primary caregiver (18 years and older) of children 4-17 years of age - Children/adolescents who have a diagnosis of asthma, and have documented poor control as evidenced by requiring two or more systemic steroids, one or more hospitalizations and/or two or more ED visits due to asthma in the 12 months prior to the asthma clinic or hospital visit. - Patients and caregivers will be English or Spanish speaking. Exclusion Criteria: - children < 4 yrs of age - children with multiple chronic lung diseases - Children and families whose primary language is other than English or Spanish |
| Country | Name | City | State |
|---|---|---|---|
| United States | Children's Hospital Colorado | Aurora | Colorado |
| Lead Sponsor | Collaborator |
|---|---|
| University of Colorado, Denver |
United States,
Bäuerle K, Feicke J, Scherer W, Spörhase U, Bitzer EM. Evaluation of a standardized patient education program for inpatient asthma rehabilitation: Impact on patient-reported health outcomes up to one year. Patient Educ Couns. 2017 May;100(5):957-965. doi: 10.1016/j.pec.2016.11.023. Epub 2016 Nov 28. — View Citation
Boulet LP, Boulay MÈ, Gauthier G, Battisti L, Chabot V, Beauchesne MF, Villeneuve D, Côté P. Benefits of an asthma education program provided at primary care sites on asthma outcomes. Respir Med. 2015 Aug;109(8):991-1000. doi: 10.1016/j.rmed.2015.05.004. Epub 2015 May 14. — View Citation
CDC - Asthma - Data and Surveillance - Asthma Surveillance Data. (2016, September 8). Retrieved from https://www.cdc.gov/asthma/asthmadata.htm
McCarty K, Rogers J. Inpatient asthma education program. Pediatr Nurs. 2012 Sep-Oct;38(5):257-62, 269; quiz 263. — View Citation
National Heart Lung and Blood Institute (US). Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma Clinical Practice Guidelines National Asthma Education and Prevention Program, Third Expert Panel on the Diagnosis and Management of Asthma. http://www.nhlbi.nih. gov/guidelines/asthma/asthgdln.htm (Accessed March 19 2018).
Nurmagambetov T, Kuwahara R, Garbe P. The Economic Burden of Asthma in the United States, 2008-2013. Ann Am Thorac Soc. 2018 Mar;15(3):348-356. doi: 10.1513/AnnalsATS.201703-259OC. — View Citation
Srof B, Taboas P, Velsor-Friedrich B. Adolescent asthma education programs for teens: review and summary. J Pediatr Health Care. 2012 Nov-Dec;26(6):418-26. doi: 10.1016/j.pedhc.2011.03.010. Epub 2011 May 12. Review. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change the number of hospital visits of participants with asthma | Change the number of hospital visits of participants with asthma through comprehensive asthma education | 12 months from completion of the classroom sessions | |
| Primary | Change the number of emergency room or urgent care visits of participants with asthma | Change the number of emergency room or urgent care visits of participants with asthma through comprehensive asthma education | 12 months from completion of the classroom sessions | |
| Primary | Change the amount of oral steroids taken by the participants for asthma exacerbations | Change the amount of oral steroids taken by participants for asthma exacerbation through comprehensive asthma education | 12 months from completion of the educational sessions |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|